Cargando…

Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

BACKGROUND: Chemoprophylactics against emerging epidemic and pandemic infectious diseases offer potential for prevention but require efficacy and safety analysis before widespread use can be recommended. Chemoprophylaxis with repurposed drugs enables deployment ahead of development of novel vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manoharan, Lakshmi, Olliaro, Piero, Horby, Peter W., Watson, Conall H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164073/ https://www.ncbi.nlm.nih.gov/pubmed/34051840 http://dx.doi.org/10.1186/s13063-021-05323-4

Ejemplares similares

Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review
por: Manoharan, Lakshmi, et al.
Publicado: (2021)

Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic
por: Rojek, Amanda M, et al.
Publicado: (2018)

Performance of different clinical trial designs to evaluate treatments during an epidemic
por: Brueckner, Matthias, et al.
Publicado: (2018)

Chemoprophylaxis in Medicine and Surgery
por: O'Grady, F. W.
Publicado: (1972)

A Systematic Review of Economic Evaluations of Chemoprophylaxis for Tuberculosis
por: Chavan, Shraddha, et al.
Publicado: (2011)

Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
por: Tan, Kathrine R., et al.
Publicado: (2011)

Global challenges in preparedness and response to epidemic infectious diseases
por: Olliaro, Piero, et al.
Publicado: (2022)

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
por: Manjunath, B.G., et al.
Publicado: (2020)

Chemoprophylaxis and Malaria Death Rates
por: Krause, Gérard, et al.
Publicado: (2006)

Chemoprophylaxis of Tropical Infectious Diseases
por: McBride, William J. H.
Publicado: (2010)

Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
por: Cooper, Ben S., et al.
Publicado: (2015)

Chemoprophylaxis in Contacts of Patients with Cholera: Systematic Review and Meta-Analysis
por: Reveiz, Ludovic, et al.
Publicado: (2011)

Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
por: Patrì, Angela, et al.
Publicado: (2020)

The potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19
por: AbdelMassih, Antoine, et al.
Publicado: (2021)

Pre-exposure chemoprophylaxis for HIV: It is time
por: Smith, Stephen M
Publicado: (2004)

Rational malaria chemoprophylaxis – The position of primaquine
por: Baird, J. Kevin
Publicado: (2017)

Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness
por: Olliaro, Piero L., et al.
Publicado: (2019)

Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems
por: McCabe, Ruth, et al.
Publicado: (2023)

Modernising epidemic science: enabling patient-centred research during epidemics
por: Rojek, Amanda M., et al.
Publicado: (2016)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

Enabling Factors for Improved Malaria Chemoprophylaxis Compliance
por: Diara, Malick, et al.
Publicado: (2012)

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy
por: Duthie, Malcolm S, et al.
Publicado: (2016)

Large contractors in Africa: conundrums with malaria chemoprophylaxis
por: Braack, Leo
Publicado: (2016)

Chemoprophylaxis is Cost-Effective in Total Ankle Arthroplasty
por: Martinazzi, Brandon J., et al.
Publicado: (2022)

Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021)

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
por: Salam, Alex P., et al.
Publicado: (2022)

A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project
por: Merle, Corinne SC, et al.
Publicado: (2012)

What does 95% COVID-19 vaccine efficacy really mean?
por: Olliaro, Piero
Publicado: (2021)

Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review
por: Padmapriyadarsini, C., et al.
Publicado: (2018)

Chemoprophylaxis for the prevention of tuberculosis in kidney transplant recipients: A systematic review and meta-analysis
por: Yuan, Zhihui, et al.
Publicado: (2023)

A living systematic review protocol for COVID-19 clinical trial registrations
por: Maguire, Brittany J., et al.
Publicado: (2020)

Determining utility values related to malaria and malaria chemoprophylaxis
por: McCarthy, Anne E, et al.
Publicado: (2010)

Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis
por: Nevin, Remington L
Publicado: (2009)

Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique
por: Gobbi, Federico, et al.
Publicado: (2013)

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++
por: Mieras, Liesbeth F, et al.
Publicado: (2018)

Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries
por: Kayem, Nzelle Delphine, et al.
Publicado: (2019)

Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design
por: Merson, Laura, et al.
Publicado: (2021)

Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis
por: Chopra, Arvind, et al.
Publicado: (2021)

GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic
por: Whitehead, John, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j4pnl21mhmlsdu7n1c2jou27sn